Ceribell Inc., a medical-device maker that uses artificial intelligence to monitor patient seizures, was on track for a strong trading debut Friday, after its initial public offering priced at the top of its proposed range.
More Stories
Amazon faces $1.5 billion Project Kuiper headwind in 2025 after satellite launch delay: Morgan Stanley
Amazon’s ambitious Project Kuiper satellite constellation aims to build a system of 3,236 satellites to increase global broadband access.
Here’s how stocks have performed under Biden and Harris vs. under Trump
During the homestretch of the tight presidential race, the campaigns of Democratic nominee Kamala Harris and Republican rival Donald Trump...
Pfizer wins FDA approval for hemophilia B drug that will be first once-weekly treatment
The new drug would allow patients to produce the needed clotting protein for an extended period, reducing the need for...
Hurricanes Helene and Milton unlikely to depress U.S. GDP
Hurricanes Milton and Helene put lots of people out of work temporarily and could add upward pressure to inflation, but...
Can Nvidia have another blowout year in 2025?
Also: New ways to learn about financial risks before buying a home, thoughts on the bull market for stocks and...
JPMorgan CEO Dimon: Cash is very valuable when the future looks ‘treacherous’
JPMorgan Chase CEO Jamie Dimon believes stock prices are “inflated” and seems very worried about the future, so he’s in...